S
Shandong Boan Biotechnology Co Ltd
HKEX:6955
Shandong Boan Biotechnology Co Ltd
HKEX:6955
Price:
7.84
HKD
1.16%
Market Cap:
HK$4.9B
Relative Value
The Relative Value of one Shandong Boan Biotechnology Co Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 7.84 HKD, Shandong Boan Biotechnology Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Shandong Boan Biotechnology Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Shandong Boan Biotechnology Co Ltd Competitors
Shandong Boan Biotechnology Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
S
|
Shandong Boan Biotechnology Co Ltd
HKEX:6955
|
4.5B HKD | 5.3 | 125 | 23.9 | 52 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
386.2B USD | 6.5 | 164.5 | 16 | 22.7 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
196.7B USD | 5.5 | 28.1 | 19.9 | 19.9 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
185.2B USD | 6.4 | 22.8 | 15.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
116.4B USD | 9.9 | 31.7 | 23.2 | 24.3 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.9B USD | 5.6 | 18 | 15.2 | 17.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
87.7B AUD | 3.9 | 20.2 | 13.5 | 16.8 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.9B EUR | 14.5 | 34 | 58.1 | 59.7 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
